Pharma-backed petition calls on FDA to reform release of drug rejection letters

The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters. The law firm Covington & Burling, on behalf of an unnamed pharmaceutical company ...